Triflusal Triflusal Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade names include Disgren, Grendis, Aflen and Triflux. Triflusal is a selective platelet antiaggregant through; Triflusal is indicated for; In the 2008 guidelines for stroke management from the European Stroke Organization, triflusal was for the first time recommended as lone therapy, as an alternative to acetylsalicylic acid
Endiandric acid C Endiandric acid C Endiandric acid C, isolated from the tree "Endiandra introrsa", is a well characterized chemical compound. Endiadric acid C is reported to have better antibiotic activity than ampicillin. This genus of trees is in the family Lauraceae. These trees are found in the north-eastern Australian rainforests and other tropical and subtropical regions. However, they are also found in southern Canada and in Chile. Endiandric acid C is also isolated from the species "E. xanthocarpa". Endiandric acids are also found in "Beilschmiedia" trees, which were categorized under the genus "Endiandra", but moved to their own genus as they found